| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Obstetrics and Gynecology (C.M.D., R.A.), Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Obstetrics and Gynecology (C.M.D., R.A.), The David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90095; and Departments of Biostatistics and Biomathematics (K.S.W., A.A.B.) and Obstetrics and Gynecology (R.A.), University of Alabama at Birmingham, Birmingham, Alabama 35294
Address all correspondence and requests for reprints to: Ricardo Azziz, M.D., M.P.H., M.B.A., Cedars-Sinai Medical Center, Department of Obstetrics and Gynecology, 8635 West Third Street, Suite 160 W, Los Angeles, California 90048. E-mail: azzizr{at}cshs.org.
Context: Hirsutism (i.e. facial and body terminal hair growth in a male-like pattern in women) is the principal clinical sign of hyperandrogenism, although its definition remains unclear.
Objective: The purposes of the present study were to define 1) the degree of facial and body terminal hair, as assessed by the modified Ferriman-Gallwey (mFG) score, in unselected women from the general population; 2) the effect of race (Black and White) on the same; and 3) the normative cutoff values.
Design and Setting: We conducted a prospective observational study at a tertiary academic medical center.
Patients/Participants: Participants included 633 unselected White (n = 283) and Black (n = 350) women presenting for a preemployment physical exam.
Interventions: Interventions included history and physical examination.
Main Outcome Measures: Terminal body hair growth was assessed using the mFG scoring system; nine body areas were scored from 04 for terminal hair growth distribution.
Results: The mFG scores were not normally distributed; although cluster analysis failed to identify a natural cutoff value or clustering of the population, principal component and univariate analyses denoted two nearly distinct clusters that occurred above and below an mFG value of 2, with the bulk of the scores below. Overall, an mFG score of at least 3 was observed in 22.1% of all subjects (i.e. the upper quartile); of these subjects, 69.3% complained of being hirsute, compared with 15.8% of women with an mFG score below this value, and similar to the proportion of women with an mFG score of at least 8 who considered themselves to be hirsute (70.0%). Overall, there were no significant differences between Black and White women.
Conclusions: Our data indicate that the prevalence and degree of facial and body terminal hair growth, as assessed by the mFG score, is similar in Black and White women and that an mFG of at least 3 signals the population of women whose hair growth falls out of the norm.
This article has been cited by other articles:
![]() |
B. O. Yildiz, S. Bolour, K. Woods, A. Moore, and R. Azziz Visually scoring hirsutism Hum. Reprod. Update, June 30, 2009; (2009) dmp024v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Koulouri and G. S Conway Management of hirsutism BMJ, March 27, 2009; 338(mar27_1): b847 - b847. [Full Text] |
||||
![]() |
S. J. Chae, J. J. Kim, Y. M. Choi, K. R. Hwang, B. C. Jee, S. Y. Ku, C. S. Suh, S. H. Kim, J. G. Kim, and S. Y. Moon Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women Hum. Reprod., August 1, 2008; 23(8): 1924 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
Does {blacktriangledown}eflornithine help women face hirsutism? DTB, August 1, 2007; 45(8): 62 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H. F. Escobar-Morreale, W. Futterweit, O. E. Janssen, R. S. Legro, R. J. Norman, A. E. Taylor, et al. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4237 - 4245. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |